In vitro Characterization of Novel Peptide Inhibitors of Endomorphin‐degrading Enzymes in the Rat Brain
Authors:
- Jakub FichnaJFJakub Fichna
- Anna JaneckaAJAnna Janecka
- Laetitia BaillyLBLaetitia Bailly
- Francis MarsaisFMFrancis Marsais
- Jean CostentinJCJean Costentin
- Jean‐Claude Do RegoJRJean‐Claude Do Rego
- 1 September 2006
- journal article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 68 (3) , 173-175
Abstract
Endomorphins, endogenous mu-opioid receptor ligands, have been shown to exert antinociceptive, antidepressant, anxiolytic, and neuromodulatory effects, as well as to influence cardiovascular, respiratory, and gastrointestinal systems. In the present study, we designed and synthesized a series of tetrapeptides and tripeptides (amides and peptide acids) of similar to endomorphins structure, but with low mu-opioid receptor affinity, and tested them as possible inhibitors of endomorphin-degrading enzymes. The obtained results indicate that the tripeptides Tyr-Pro-Ala-NH2 and Tyr-Pro-Ala-OH, which do not bind to the mu-opioid receptors, are potent inhibitors of endomorphin-degrading enzymes in the rat brain. We suggest that the in vivo administration of these novel analogs may enhance physiological effects of endogenous endomorphins by decreasing the rate of their enzymatic cleavage.Keywords
This publication has 11 references indexed in Scilit:
- Functional Characterization of Opioid Receptor Ligands by Aequorin Luminescence-Based Calcium AssayThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Enzymatic degradation studies of endomorphin-2 and its analogs containing N-methylated amino acidsPeptides, 2006
- Characterization of antinociceptive activity of novel endomorphin-2 and morphiceptin analogs modified in the third positionBiochemical Pharmacology, 2005
- In vitro quantitative study of the degradation of endomorphinsPeptides, 2002
- Endomorphin‐1 and ‐2, endogenous ligands for the μ‐opioid receptor, inhibit striated and smooth muscle contraction in the rat oesophagusNeurogastroenterology & Motility, 2000
- Differential Cardiorespiratory Effects of Endomorphin 1, Endomorphin 2, DAMGO, and MorphineAmerican Journal of Respiratory and Critical Care Medicine, 2000
- The Endogenous Mu-Opioid Receptor Agonists Endomorphins 1 and 2 Have Novel Hypotensive Activity in the RabbitBiochemical and Biophysical Research Communications, 1997
- A potent and selective endogenous agonist for the µ-opiate receptorNature, 1997
- Dynorphin-(1-13), an extraordinarily potent opioid peptide.Proceedings of the National Academy of Sciences, 1979
- Identification of two related pentapeptides from the brain with potent opiate agonist activityNature, 1975